Healthcare / Medical Care FacilitiesIstanbul
$17.04
-0.54 (-3.07%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 16%
FCF escenarios
weak_data · normalized FCF $-48.8M · quality 33.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
45/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$3.7B
P/E
26.2x
↑EV/EBITDA
7.1x
↓ROE
6.4%
↑Gross Margin
17.7%
↓Debt/Equity
1.06
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+36.7%
FCF CAGR
—
FCF margin
-16.7%
FCF / Net income
-4.70x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $4.23B · net income $150.3M · FCF $-705.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.23B | $4.23B | $3.85B | $2.74B | $1.66B |
| Net Income | $150.3M | $150.3M | $313.9M | $465.1M | $316.9M |
| EBITDA | $854.5M | $854.5M | $1.33B | $955.2M | $676.8M |
| EPS | 0.70 | 0.70 | 1.45 | 2.15 | 1.47 |
| Gross Margin | 17.7% | 17.7% | 17.3% | 14.0% | 12.3% |
| Operating Margin | 9.4% | 9.4% | 9.2% | 9.1% | 7.8% |
| Net Margin | 3.6% | 3.6% | 8.2% | 17.0% | 19.1% |
| Balance Sheet | |||||
| Debt/Equity | 1.06 | 1.06 | 0.59 | 0.42 | 0.64 |
| Current Ratio | 0.83 | 0.83 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-705.9M | $-705.9M | $-48.8M | $238.3M | $-72.8M |
| Returns | |||||
| ROE | 6.4% | 6.4% | 12.6% | 25.9% | 32.0% |
| Valuation | |||||
| P/E | 26.22 | 26.22 | 12.62 | 3.84 | 3.42 |
| EV/EBITDA | 7.06 | 7.06 | 3.99 | 2.61 | 2.43 |
| P/B | 1.56 | 1.56 | 1.59 | 1.00 | 1.10 |
| Growth & Yield | |||||
| Revenue Growth | 10.0% | 10.0% | 40.7% | 65.0% | — |
| EPS Growth | -52.1% | -52.1% | -32.5% | 46.8% | — |
| Dividend Yield | 2.6% | 2.6% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
29.5%
EPS terminal req.
$1.51
Spread vs growth
-81.6%
5Y implied EPS CAGR
21.3%
EPS terminal req.
$1.83
Spread vs growth
-73.4%
10Y implied EPS CAGR
15.5%
EPS terminal req.
$2.95
Spread vs growth
-67.6%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+17.8%
Start / end P/E
10.2x → 24.5x
EPS bridge
1.45 → 0.70
Residual
-73.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.